Top

International Journal of Mental Health and Addiction

Published in:

Open Access 05-10-2021 | Codeine | Original Article

Physician Perspectives on Codeine Accessibility, Patterns of Use, Misuse, and Dependence in Saudi Arabia

Authors: Mamoon H. Syed, Ayesha Yasmeen, Marie-Claire Van Hout

Published in: International Journal of Mental Health and Addiction | Issue 3/2023

Abstract

In Saudi Arabia, there are concerning rates of non-compliance with pharmaceutical regulations prohibiting the pharmacy dispensing of prescription-only medications without a physician prescription. This is the first study in the Middle East which examines physicians’ perceptions regarding misuse of codeine, listed as a narcotic, controlled, and prescription-only drug. The CODEMISUSED survey was adapted to the Saudi Arabian context and pilot tested, prior to cross-sectional administration to physicians in Riyadh, Jeddah, Abha, and Jazan (n = 105). Descriptive statistics (frequencies and percentage) present physician level of agreement, neutrality, and disagreement with statements regarding codeine prescribing, patient awareness and use, online and community pharmacy availability, and dependence. The study indicates concern by physicians regarding patient intentional use of codeine to enhance mood, misuse patterns, lack of awareness around habit-forming use and iatrogenic dependence, and sourcing via illegal dispensing. It underscores the imperatives to address pharmacy compliance with pharmaceutical regulatory controls, implement enhanced pharmacovigilance, and improve awareness around safe use.

Abomughaid MM, Tayrab EMA, Alghamdi AA. (2018). Prevalence of cannabis and amphetamine in Aseer Region, Saudi Arabia: A retrospective study. Int J Collaborative Research on Internal Medicine & Public Health, 10(2) Available at Prevalence of cannabis and amphetamine in Aseer Region, Saudi Arabia: a retrospective study | Insight Medical Publishing (imedpub.com)

Abualola, T. H., & Rahamathulla, M. A. (2017). A review of policies and treatments for addiction to hard drugs: Saudi Arabia, the Netherlands, and Australia. Egyptian J Social Work, 3(1), 43–64.CrossRef

Al Harbi K (2017). المشكلات التي تواجه أسر مدمني المخدرات في المجتمع السعودي . [Problems faced by families of drug addicts in the Saudi Society][In Arabic]. Annals of Arts & Social Sciences, 38.

Alharbi, H. A., Albabtain, M. A., Alobiad, N., Aba Alhasan, J., Alruhaimi, M., Alnefisah, M., Alateeq, S., Alghosoon, H., Alarfaj, S. J., Arafat, A. A., & Algarni, K. D. (2020). Pain perception assessment using the short-form McGill pain questionnaire after cardiac surgery. Saudi Journal of Anaesthesia, 14(3), 343–348. https://doi.org/10.4103/sja.SJA_34_20CrossRefPubMedPubMedCentral

Alhazmi, H. A., Ahsan, W., Al Bratty, M., Javed, S. A., El-Sharkawy, K. A., Khalid, A., Alsalem, H. M., Hakami, A. M., Attafi, M. A., & Oraiby, M. E. (2020). Analysis of amphetamine and methamphetamine contents in seized tablets from Jazan, Saudi Arabia by liquid chromatography-mass spectroscopy (LC-MS/MS) and chemometric techniques. Saudi Pharm J, 28(6), 703–709. https://doi.org/10.1016/j.jsps.2020.04.012CrossRefPubMedPubMedCentral

Alibrahim, O., Elawad, N., Misau, Y. A., Shaikh, T. M., & Allam, N. (2012). Drug dependence and psychotic symptoms: A retrospective study of adolescents who abuse drugs at Al-Amal Hospital in Jeddah Saudi Arabia. J Public Health Afr, 3(1), e5. https://doi.org/10.4081/jphia.2012.e5CrossRefPubMedPubMedCentral

Aljadhey, H., Assiri, G. A., Mahmoud, M. A., Al-Aqeel, S., & Murray, M. (2015). Self-medication in Central Saudi Arabia Community pharmacy consumers’ perspectives. Saudi Med J, 36(3), 328–34. https://doi.org/10.15537/smj.2015.3.10523CrossRefPubMedPubMedCentral

AlKhamees, O. A., AlNemer, K. A., Bin Maneea, M. W., AlSugair, F. A., AlEnizi, B. H., & Alharf, A. A. (2018). Top 10 most used drugs in the Kingdom of Saudi Arabia 2010–2015. Saudi Pharm J, 26(2), 211–216. https://doi.org/10.1016/j.jsps.2017.12.009CrossRefPubMed

Al-Mohamadi, A., Badr, A., Bin Mahfouz, L., Samargandi, D., & Al, A. A. (2013). Dispensing medications without prescription at Saudi community pharmacy: Extent and perception. Saudi Pharm J, 21(1), 13–18. https://doi.org/10.1016/j.jsps.2011.11.003CrossRefPubMed

Alomi, Y. A. (2017). National pharmacy pain management program at ministry of health in Saudi Arabia. J Pharmacol Clin Res, 3(2), 1–7.CrossRef

Al-Rowaili, A., Al-aqeel, S. A., Al-Naim, L. S., & Al-Diab, A. I. (2009). Appropriateness of cancer pain management in Saudi teaching hospital. Gulf J Oncolog, 5, 37–43.

AlRuthia, Y., Alhazzani, H., Alhindi, G., Alarfaj, M., Almutairi, L., Alanazi, M., Alokili, K., Alanazi, N., Alodaibi, F., Alwhaibi, M., Bashatah, A. S., Asiri, Y., & Alsanawi, H. (2020). Predictors of opioid prescription among a sample of patients with acute musculoskeletal pain at a tertiary care hospital in Saudi Arabia. Journal of Pain Research, 13, 2929–2936. https://doi.org/10.2147/JPR.S276630CrossRefPubMedPubMedCentral

Alshammari, T. M., Alhindi, S. A., Alrashdi, A. M., Benmerzouga, I., & Aljofan, M. (2017). Pharmacy malpractice: The rate and prevalence of dispensing high-risk prescription-only medications at community pharmacies in Saudi Arabia. Saudi Pharm J, 25(5), 709–714. https://doi.org/10.1016/j.jsps.2016.10.001CrossRefPubMed

Alshomrani, A. T., Khoja, A. T., Alseraihah, S. F., & Mahmoud, M. A. (2017). Drug use patterns and demographic correlations of residents of Saudi therapeutic communities for addiction. J Taibah Univ Med Sci, 12(4), 304–312. https://doi.org/10.1016/j.jtumed.2017.02.006CrossRefPubMedPubMedCentral

American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders. DSM V-5th edition APA, VA.

Bamofleh, E. A., Mohammed, J. A., Abdelrahim, M. E., & Gamal, M. (2017). The reasons behind prevalence of Captagon addiction in Jeddah and community awareness: A questionnaire-based study. Pharmaceutical Analytical Chemistry, 2017(1), 20.

Barreto, S. G., Tiong, L., & Williams, R. (2011). Drug-induced acute pancreatitis in a cohort of 328 patients A Single-Centre Experience from Australia. JOP, 12(6), 581–585.PubMed

Bassiony, M. (2013). Substance use disorders in Saudi Arabia: Review article. J Substance Use, 18(6), 450–466. https://doi.org/10.3109/14659891.2011.606349CrossRef

Bergin, M., Norman, I., Foley, M., Harris, R., Rapca, A., Rich, E., & Van Hout, M. C. (2015). Practice implications and recommendations for managing codeine misuse and dependence. Acta Pharmacologica, 65, 351–364.CrossRef

Carney, T., Wells, J. S., Bergin, M., Dada, S., Foley, M., McGuinness, P., Rapca, A., Rich, E., & Van Hout, M. C. (2016). A comparative exploration of pharmacists’ views on the nature and management of over-the-counter (OTC) and prescription codeine misuse in three regulatory regimes: Ireland, South Africa and the United Kingdom. Int J Mental Health Addiction, 14(4), 351–369. https://doi.org/10.1007/s11469-016-9640-zCrossRef

Carney, T., Wells, J., Parry, C. D. H., McGuinness, P., Harris, R., & Van Hout, M. C. (2018). A comparative analysis of pharmacists’ perspectives on codeine use and misuse - A three country survey. Subst Abuse Treat Prev Policy, 13(1), 12. https://doi.org/10.1186/s13011-018-0149-2CrossRefPubMedPubMedCentral

Casati, A., Sedefov, R., & Pfeiffer-Gerschel, T. (2012). Misuse of medicines in the European Union: A systematic review of the literature. European Addiction Research, 18(5), 228–245. https://doi.org/10.1159/000337028CrossRefPubMed

Chetty, R., Baoku, Y., Mildner, R., Banerjee, A., Vallance, D., Haddon, A., & Labib, M. (2003). Severe hypokalaemia and weakness due to Nurofen misuse. Annals of Clinical Biochemistry, 40(Pt 4), 422–423. https://doi.org/10.1258/000456303766477101CrossRefPubMed

Cleary J, Silbermann M, Scholten W, et al. (2013). Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: A report from the Global Opioid Policy Initiative (GOPI). Ann Oncol, 2013; 24(11):xi51–xi59. https://doi.org/10.1093/annonc/mdt503

Dada, S., Harker Burnhams, N., Van Hout, M. C., & Parry, C. D. (2015). Codeine misuse and dependence in South Africa-Learning from substance abuse treatment admissions. South African Medical Journal , 105(9), 776–779. https://doi.org/10.7196/SAMJnew.8172CrossRefPubMed

Dutch, M. J. (2008). Nurofen Plus misuse: An emerging cause of perforated gastric ulcer. Medical Journal of Australia, 188(1), 56–57. https://doi.org/10.5694/j.1326-5377.2008.tb01509.xCrossRefPubMed

Foley, M., Harris, R., Rich, E., Rapca, A., Bergin, M., Norman, I., & Van Hout, M. C. (2015). The availability of over-the-counter codeine medicines across the European Union. Public Health, 129(11), 1465–1470. https://doi.org/10.1016/j.puhe.2015.06.014CrossRefPubMed

Foley, M., Carney, T., Rich, E., Parry, C., Van Hout, M. C., & Deluca, P. (2016). Medical professionals’ perspectives on prescribed and over-the-counter medicines containing codeine: A cross-sectional study. British Medical Journal Open, 6(7), e011725. https://doi.org/10.1136/bmjopen-2016-011725CrossRef

Foley, M., Carney, T., Harris, R., Fitzpatrick, E., Rapca-Veillet, A., & Van Hout, M. C. (2017). Medicines containing codeine: Perspectives of medical professionals in the Republic of Ireland. Irish Journal of Medical Science, 186(3), 555–563. https://doi.org/10.1007/s11845-016-1546-zCrossRefPubMed

Foley, M., Carney, T., Rich, E., Dada, S., Mburu, C., & Parry, C. (2018). A study of medical professionals’ perspectives on medicines containing codeine in South Africa. S Afr J Psychiatr, 24, 1162. https://doi.org/10.4102/sajpsychiatry.v24.i0.1162CrossRefPubMedPubMedCentral

Girelli, G. (2019). The death penalty for drug offences: Global Overview 2018, Harm Reduction International United Kingdom, 2019. Available at The Death Penalty for Drug Offences | Harm Reduction International (hri.global)

Hurwitz J, Sands S, Davis E, Nielsen J, Warholak T. (2014). Patient knowledge and use of acetaminophen in over-the-counter medications. J Am Pharm Assoc (2003), 54(1):19–26. https://doi.org/10.1331/JAPhA.2014.13077

Hussain, A., Ibrahim, M. I., & Baber, Z. U. (2012). Compliance with legal requirements at community pharmacies: A cross sectional study from Pakistan. The International Journal of Pharmacy Practice, 20(3), 183–190. https://doi.org/10.1111/j.2042-7174.2011.00178.xCrossRefPubMed

Ibrahim, Y., Hussain, S. M., Alnasser, S., Almohandes, H., & Sarhandi, I. (2018). Patterns and sociodemographic characteristics of substance abuse in Al Qassim, Saudi Arabia: A retrospective study at a psychiatric rehabilitation center. Annals of Saudi Medicine, 38(5), 319–325. https://doi.org/10.5144/0256-4947.2018.319CrossRefPubMedPubMedCentral

Katsarava, Z., & Jensen, R. (2007). Medication-overuse headache: Where are we now? Current Opinion in Neurology, 20(3), 326–330. https://doi.org/10.1097/WCO.0b013e328136c21cCrossRefPubMed

Katselou, M., Papoutsis, I., Nikolaou, P., Qammaz, S., Spiliopoulou, C., & Athanaselis, S. (2016). Fenethylline (Captagon) Abuse - Local problems from an old drug become universal. Basic & Clinical Pharmacology & Toxicology, 119(2), 133–140. https://doi.org/10.1111/bcpt.12584CrossRef

Kingdom of Saudi Arabia-Ministry of Health (2014). Formulary drug list. Available at https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/MOH_FormularyDrugList2014.pdf

Kravitz, M., & Nichols, W. (2016). A bitter pill to swallow: Connections between captagon, Syria, and the Gulf. J Int Affairs, 69(2), 31–44.

Middle East and North Africa Harm Reduction Association (MENAHRA). (2021). Situation on Assessment of Situation and Response of Drug Use and its Harms in the Middle East and North Africa 2020. Retrieved from http://www.menahra.org/images/pdf/Situation_Assessment_2021_-_Web.pdf

Mobrad, A. M., Alghadeer, S., Syed, W., Al-Arifi, M. N., Azher, A., Almetawazi, M. S., & Babelghaith, S. D. (2020). Knowledge, attitudes, and beliefs regarding drug abuse and misuse among community pharmacists in Saudi Arabia. International Journal of Environmental Research and Public Health, 17(4), 1334. https://doi.org/10.3390/ijerph17041334CrossRefPubMedPubMedCentral

Moore, A., Collins, S., Carroll, D., McQuay, H., Edwards, J. (2001). Single dose paracetamol (acetaminophen) with and without codeine for postoperative pain. Cochrane Libr, (2):CD001547. https://doi.org/10.1002/14651858.CD001547

Myers, B., Siegfried, N., & Parry, C. D. (2003). Over-the-counter and prescription medicine misuse in Cape Town-Findings from specialist treatment centres. South African Medical Journal, 93(5), 367–370.PubMed

Ng, J. L., Morgan, D. J., Loh, N. K., Gan, S. K., Coleman, P. L., Ong, G. S., & Prentice, D. (2011). Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis. Medical Journal of Australia, 194(6), 313–316. https://doi.org/10.5694/j.1326-5377.2011.tb02982.xCrossRefPubMed

Nielsen, S., Tobin, C., & Dobbin, M. (2012). OTC codeine: Examining the evidence for and against. Aust Phar, 31(3), 236.

Nielsen, S., Van Hout, M.C. (2015). Over-the-counter codeine—From therapeutic use to dependence, and the grey areas in between. In 'The Misuse of Licit and Illicit Drugs in Psychopharmacology'. Bart Ellenbroek, Mark Geyer and Charles Marsden (Eds). Current Topics in Behavioral Neuroscience, Springer Link, 1–17. https://doi.org/10.1007/7854_2015_422

Norman, I. J., Bergin, M., Parry, C. D., & Van Hout, M. C. (2016). Best practices and innovations for managing codeine misuse and dependence. Journal of Pharmacy & Pharmaceutical Sciences, 19(3), 367–381. https://doi.org/10.18433/J3T89KCrossRef

Parry, C. D., Deluca, P., Cooper, R., & Van Hout, M. C. (2015). Do we have sufficient information to optimally inform regulatory or other policy decisions about medications containing codeine? Addiction, 110(10), 1690–1691. https://doi.org/10.1111/add.13047CrossRefPubMed

Parry, C. D. H., Rich, E., Van Hout, M. C., & Deluca, P. (2017). Codeine misuse and dependence in South Africa: Perspectives of addiction treatment providers. South African Medical Journal , 107(5), 451–456. https://doi.org/10.7196/SAMJ.2017.v107i5.12242CrossRefPubMed

Romach, M. K., Sproule, B. A., Sellers, E. M., Somer, G., & Busto, U. E. (1999). Long-term codeine use is associated with depressive symptoms. Journal of Clinical Psychopharmacology, 19(4), 373–376. https://doi.org/10.1097/00004714-199908000-00015CrossRefPubMed

Sabry, N. A., Farid, S. F., & Dawoud, D. M. (2014). Antibiotic dispensing in Egyptian community pharmacies: An observational study. Research in Social & Administrative Pharmacy, 10(1), 168–184. https://doi.org/10.1016/j.sapharm.2013.03.004CrossRef

Salter, M. D. (2013). Ibuprofen-induced hypokalemia and distal renal tubular acidosis: A patient’s perceptions of over-the-counter medications and their adverse effects. Case Rep Crit Care, 2013, 875857. https://doi.org/10.1155/2013/875857CrossRefPubMedPubMedCentral

Saquib, N., Rajab, A. M., Saquib, J., & AlMazrou, A. (2020). Substance use disorders in Saudi Arabia: A scoping review. Subst Abuse Treat Prev Policy, 15(1), 41. https://doi.org/10.1186/s13011-020-00285-3CrossRefPubMedPubMedCentral

Saudi Food and Drugs Authority (SFDA)(2021). Available at https://www.sfda.gov.sa/en/drugs-list).

Siddiqui, A. F., & Salim, A. M. A. (2016). Awareness of substance use and its associated factors in young Saudi students. J Med Allied Sci, 6(2), 61–67.CrossRef

Sweileh, W. M., Zyoud, S. H., Al-Jabi, S. W., & Sawalha, A. F. (2014). Substance use disorders in Arab countries: Research activity and bibliometric analysis. Subst Abuse Treat Prev Policy, 9, 33. https://doi.org/10.1186/1747-597X-9-33CrossRefPubMedPubMedCentral

Tobin, C. L., Dobbin, M., & McAvoy, B. (2013). Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom. Australian and New Zealand Journal of Public Health, 37(5), 483–488. https://doi.org/10.1111/1753-6405.12099CrossRefPubMed

United Nations Office on Drugs and Crime (UNODC). (2020). World Drug Report 2020. UNODC, Austria, 2020. Available at World Drug Report 2020 (unodc.org)

Van Hout, M. C. (2014). Doctor shopping and pharmacy hopping: Practice innovations relating to codeine. Drug Alcohol Today, 14(4), 219–234. https://doi.org/10.1108/DAT-03-2014-0014CrossRef

Van Hout, M. C., & Norman, I. (2016). Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies. The International Journal on Drug Policy, 2016(27), 17–22. https://doi.org/10.1016/j.drugpo.2015.09.007CrossRef

Van Hout, M. C., Norman, I., Rich, E., & Bergin, M. (2017a). Experiences of codeine use, misuse and dependence: Application of Liese and Franz’s cognitive developmental model of substance abuse. Behavioural and Cognitive Psychotherapy, 45(3), 238–252. https://doi.org/10.1017/S1352465817000030CrossRefPubMed

Van Hout, M. C., Rich, E., Dada, S., & Bergin, M. (2017b). “Codeine is my helper”: Misuse of and dependence on codeine-containing medicines in South Africa. Qualitative Health Research, 27(3), 341–350. https://doi.org/10.1177/1049732315613764CrossRefPubMed

Van Hout, M. C., Horan, A., Santlal, K., Rich, E., & Bergin, M. (2018). ‘Codeine is my companion’: Misuse and dependence on codeine containing medicines in Ireland. Ir J Psychol Med, 35(4), 275–288. https://doi.org/10.1017/ipm.2015.60CrossRefPubMed

Van Hout, M.C., Bergin, M., Foley, M., Rich, E., Rapca, A.I., Harris, R., Norman, I. (2014). A scoping review of codeine use, misuse and dependence. CODEMISUSED Project. European Commission 7^th Framework Programme, EU. Brussels.

Wells, J., Bergin, M., Van Hout, M. C., McGuinness, P., Du Plessis, J., Rich, E., Dada, S., Wells, R., & Gooney, M. (2018). Purchasing Over The Counter (OTC) Medicinal products containing codeine - Easy access, advertising, misuse and perceptions of medicinal risk. Journal of Pharmacy & Pharmaceutical Sciences, 21(1), 30049. https://doi.org/10.18433/jpps30049CrossRef

Wilby, K. J., & Wilbur, K. (2017). Cross-national analysis of estimated narcotic utilization for twelve Arabic speaking countries in the Middle East. Saudi Pharm J, 25(1), 83–87. https://doi.org/10.1016/j.jsps.2016.01.001CrossRefPubMed

Title: Physician Perspectives on Codeine Accessibility, Patterns of Use, Misuse, and Dependence in Saudi Arabia
Authors: Mamoon H. Syed
Ayesha Yasmeen
Marie-Claire Van Hout
Publication date: 05-10-2021
Publisher: Springer US
Keyword: Codeine
Published in: International Journal of Mental Health and Addiction / Issue 3/2023
Print ISSN: 1557-1874
Electronic ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-021-00670-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Physician Perspectives on Codeine Accessibility, Patterns of Use, Misuse, and Dependence in Saudi Arabia

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2023

Problem Gambling and Problem Gaming in Elite Athletes: a Literature Review

The Development of the Turkish Craving for Online Shopping Scale: A Validation Study

Relationship Between Perceived Social Norms and Phubbing: Individual Control and Fear of Missing Out as Mediators

R-E-S-P-E-C-T: Psychosocial Factors Outdo Employment Conditions in Predicting Job Satisfaction and Turnover Intentions for AOD Nurses and Counsellors

Risk of First-Episode Schizophrenia in Aged Adults Increased During COVID-19 Outbreak

Predicting the Number of GHB-Related Toxicologic Admissions Using Google Trends Data